menu
    • menu

    Company profile for MindMaze Therapeutics

    NEW Drugs in Dev: 1
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Veranova: A CDMO that manages complexity with confidence.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Virtual Booth

    Contact Supplier

    Aspen API. More than just an API™

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    MindMaze is a global leader in digital neuro-therapeutics (DTx), accelerating brain recovery, learning, and adaptation. With over a decade at the intersection of neuroscience, bio-sensing, engineering, mixed reality, and AI, its healthcare division tackles neurology challenges like stroke, Alzheimer's, and Parkinson's via a universal brain health platform. Founded in 2012 by CEO Dr. Tej Tadi, the Swiss Unicorn offers FDA-clear...
    MindMaze is a global leader in digital neuro-therapeutics (DTx), accelerating brain recovery, learning, and adaptation. With over a decade at the intersection of neuroscience, bio-sensing, engineering, mixed reality, and AI, its healthcare division tackles neurology challenges like stroke, Alzheimer's, and Parkinson's via a universal brain health platform. Founded in 2012 by CEO Dr. Tej Tadi, the Swiss Unicorn offers FDA-cleared, CE-marked therapeutics from offices in Lausanne, Baltimore, London, Paris, and Mumbai.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    MindMaze TherapeuticsSwitzerland Flag
    Country
    Country
    Switzerland
    Address
    Address
    Chemin de Roseneck 5 1006 Lausanne
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://mindmazetherapeutics.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    MAGHREB Pharma Expo

    MAGHREB Pharma Expo

    Not Confirmed

    envelop Contact Supplier

    MAGHREB Pharma Expo

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Mindmaze Therapeutics Releases 2025 Annual Report & Update
    Mindmaze Therapeutics Releases 2025 Annual Report & Update

    15 Apr 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-04-15/mindmaze-therapeutics-publishes-2025-annual-report-and-corporate-update

    PHARMIWEB
    15 Apr 2026
    Share Share
    Mindmaze Therapeutics, Vibra Healthcare Unveil Breakthrough
    Mindmaze Therapeutics, Vibra Healthcare Unveil Breakthrough

    31 Mar 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-03-31/mindmaze-therapeutics-and-vibra-healthcare-announce-breakthrough-rwe-results-in-high-dose-high-inte

    PHARMIWEB
    31 Mar 2026
    Share Share
    Mindmaze Therapeutics Begins Coverage By Baader Bank
    Mindmaze Therapeutics Begins Coverage By Baader Bank

    19 Mar 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-03-19/mindmaze-therapeutics-announces-initiation-of-coverage-by-baader-bank

    PHARMIWEB
    19 Mar 2026
    Share Share
    MindMaze Names Henderson CEO to Accelerate Commercial Scaling
    MindMaze Names Henderson CEO to Accelerate Commercial Scaling

    12 Mar 2026

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/biotechnology/mindmaze-therapeutics-appoints-healthtech-veteran-zach-henderson-as-ceo-to-accelerate-1146659

    ACCESSWIRE
    12 Mar 2026
    Share Share
    MindMaze Therapeutics Updates March 2026 Presentation
    MindMaze Therapeutics Updates March 2026 Presentation

    03 Mar 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-03-03/mindmaze-therapeutics-provides-corporate-update-and-publishes-march-2026-investor-presentation

    PHARMIWEB
    03 Mar 2026
    Share Share
    Mindmaze Therapeutics Streamlines Global Reimbursement
    Mindmaze Therapeutics Streamlines Global Reimbursement

    23 Dec 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-12-23/mindmaze-therapeutics-consolidating-a-global-approach-to-reimbursement-for-next-generation-therapeu

    PHARMIWEB
    23 Dec 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search